Literature DB >> 7944684

Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma.

G W Clark1, J H Peters, A P Ireland, A Ehsan, J A Hagen, M T Kiyabu, C G Bremner, T R DeMeester.   

Abstract

The operative specimens from 43 patients undergoing en bloc esophagectomy for adenocarcinoma of the lower esophagus or cardia were analyzed. Depth of invasion of the tumor and extent and location of lymph node metastases were determined. Postoperative recurrence was identified from positive findings on successive 3-month computed tomographic scans. Positive nodes occurred in 33% (2/6) of intramucosal tumors, 67% (6/9) of intramural tumors, and 89% (25/28) of transmural tumors (p < 0.01). Commonly involved nodes were those in the lesser curve of the stomach (42%), parahiatal nodes (35%), paraesophageal nodes (28%), and celiac nodes (21%). Excluding perioperative deaths, follow-up was complete for 38 patients. Twenty patients had recurrence. Fifteen patients (40%, 15/38) had nodal recurrence: cervical, 7.9% (3/38); superior mediastinal, 21% (8/38); and abdominal, 24% (9/38) (retropancreatic in 7 and retrocrural in 2). Of 5 patients with nodal recurrence alone, 3 (60%) had recurrence at sites outside the margins of resection. Patients with four metastatic nodes or less had a survival advantage over those with more than four (p < 0.05). There was no difference in survival according to location of nodal metastases. Two (22.2%) of 9 patients with celiac node metastases survived longer than 4 years. Adenocarcinoma of the lower esophagus and cardia spreads widely to mediastinal and abdominal nodes, and death can occur from nodal disease. Rates of lymph node metastases increase with the depth of the primary tumor. Patients with lymphatic metastases can be cured particularly if there are fewer than four nodes involved. Curative surgical therapy necessitates wide lymph node resection to ensure removal of all metastatic nodes.

Entities:  

Mesh:

Year:  1994        PMID: 7944684     DOI: 10.1016/0003-4975(94)90722-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  21 in total

1.  Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction.

Authors:  L Bonavina; S Ferrero; V Midolo; R Buffa; B Cesana; A Peracchia
Journal:  J Gastrointest Surg       Date:  1999 Sep-Oct       Impact factor: 3.452

Review 2.  Pattern of lymphatic spread of Barrett's cancer.

Authors:  Marcus Feith; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

Review 3.  Surgical treatment of esophageal adenocarcinoma: concepts in evolution.

Authors:  Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

Review 4.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

5.  Improved surgical results in thoracic esophageal squamous cell carcinoma: a 40-year analysis of 792 patients.

Authors:  Hideaki Shimada; Hisahiro Matsubara; Shinichi Okazumi; Kaichi Isono; Takenori Ochiai
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

Review 6.  The significance of lymph node status as a prognostic factor for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

7.  Principles of esophageal cancer surgery, including surgical approaches and optimal node dissection (2- vs. 3-field).

Authors:  Philippe Nafteux; Lieven Depypere; Hans Van Veer; Willy Coosemans; Toni Lerut
Journal:  Ann Cardiothorac Surg       Date:  2017-03

8.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

Review 9.  Surgical management of esophageal malignancy.

Authors:  Dennis Blom
Journal:  Curr Gastroenterol Rep       Date:  2003-06

10.  Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.

Authors:  Nasser Altorki; Michael Kent; Cathy Ferrara; Jeffrey Port
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.